COMPANY INFO
Parallel Fluidics is a private manufacturing company founded in 2020 and headquartered in Boston, Massachusetts. Co-founded by CEO Joshua Gomes and COO Andy Harris, the company specializes in microfluidic device manufacturing, providing a platform that accelerates the journey from concept to scalable microfluidic products for scientific teams, enabling rapid iteration and innovation in life science technologies. Parallel Fluidics has approximately 23 employees and operates in the microfluidics and life sciences industry. Their website is https://www.parallelfluidics.com.
Parallel Fluidics is a private manufacturing company founded in 2020 and headquartered in Boston, Massachusetts. The company specializes in microfluidic device manufacturing, offering a platform that enables scientific teams to accelerate the journey from concept to scalable microfluidic products, driving innovation in life science technologies.
Parallel Fluidics executives bring together deep expertise in microfluidics, engineering, life sciences, and business management. The founding team and broader leadership group have strong scientific and technical backgrounds, complemented by commercial acumen and significant industry experience, which empowers the company’s ongoing success and rapid technology development. Together, the Parallel Fluidics management team and founders have built a culture focused on innovation, product quality, and delivering customer value.
Paul Hung leads Parallel Fluidics as CEO, focusing on the development and commercialization of proteomics platform technology and digital PCR. Under his leadership, the company has driven significant innovation in molecular diagnostics and life science tools, positively impacting research and clinical trial outcomes through advanced microfluidic solutions.
Paul Hung holds a PhD in Electrical Engineering from the University of California, Berkeley, and a Bachelor’s degree from National Taiwan University. Prior to joining Parallel Fluidics, he served as Senior Director of R&D at Thermo Fisher Scientific and as Chief Technology Officer at CellASIC Corporation, accumulating a wealth of experience in microfluidics and molecular diagnostics.
George Hvichia is a founder of Parallel Fluidics and its Chief Technology Officer, where he leads technological innovation and the development of advanced microfluidic devices for diagnostics. His work has been instrumental in advancing the company’s platform and product capabilities, positioning Parallel Fluidics as a leader in life science technology.
George Hvichia holds a PhD in Microfluidics/Biochemistry from the University of Pennsylvania. He also has extensive experience in microfluidic research and product development, especially through his leadership at ANGLE North America for over 18 years.
Charles Park steers research and development efforts at Parallel Fluidics, overseeing projects that propel innovation in microfluidic technologies for biomedical applications. He drives both strategy and execution within the R&D team, ensuring the successful launch and improvement of next-generation solutions.
Charles Park earned his Ph.D. from the University of California, Santa Barbara; M.S. from California Polytechnic State University; and B.S. from University of California, Berkeley. Prior to Parallel Fluidics, he held leadership and project management roles in R&D at Standard BioTools and GenapSys.
Robert Pelletier leads marketing and sales at Parallel Fluidics, where he has developed strategic marketing plans and driven business growth in the life sciences and medical device sectors. His expertise in sales leadership and product management has helped expand the company’s reach and revenue.
Robert Pelletier holds a BS in Biological Sciences from the University of Massachusetts Lowell and an MBA from Suffolk University – Sawyer School of Management. His prior roles include senior positions at Fluigent, Harvard Apparatus, and DiLab, where he delivered on growth, acquisitions, and new market entries.
Gunnar Ekstrand leads technology development projects focused on integrated fluidics and cartridge design, playing a key role in improving manufacturing processes for biotech instrumentation. His work underpins the company’s innovation pipeline and overall product quality.
Gunnar Ekstrand holds an MSc in Materials Physics from Uppsala University. He brings over 20 years of experience in microfluidics and systems engineering, with roles at Prevas AB, Moleculent, Cytiva, and GE Healthcare.
David Franta specializes in supporting customers in medical device development, applying lean manufacturing and Six Sigma methodologies to optimize Parallel Fluidics’ product development. He enhances user outcomes and increases process efficiency within the company’s manufacturing lines.
With a strong background in project management and product development for medical devices, David Franta is known for his expertise in process improvement and cost analysis. He is currently also associated with Solventum, bringing additional leadership to cross-functional teams.
Rob Pickles leads product development and market strategy, expanding Parallel Fluidics’ reach in life sciences and diagnostics. He spearheads efforts to build and commercialize robotic liquid handling platforms and innovative microfluidic solutions.
Rob Pickles holds a BSc and HND in Applied Biology from Nottingham Trent University. His 30+ years in the field include senior roles at Flow Robotics, Immunovia AB, Roche Diagnostics, and GE Healthcare, spanning sales, marketing, product management, and R&D.
Barry Clerkson manages the transfer of microfluidic instruments from R&D to manufacturing, refining chip interface and optical setup designs. His work optimizes prototype and high-volume manufacturing processes, ensuring product excellence.
With over 20 years of engineering experience—much of it at Fluidigm Corporation—Barry Clerkson is an accomplished innovator with expertise in optics, electronics, and microfluidic device manufacturing, and he holds several industry patents.
Joerg Martini leads research and development projects in life sciences and photonics, managing teams and securing funding for new microfluidic and bio-photonic technologies. He is known for generating patents and advancing next-generation technology platforms.
Joerg Martini holds a Dr. rer. nat. in Physics from Universität Bielefeld. He has led cutting-edge R&D at PARC, a Xerox company, and brings extensive experience in imaging, microfluidics, and life science innovation.
Stan Klein served as a CEO within the microfluidics sector, leading Parallabs Inc through significant growth phases and successful funding rounds, and holding similar executive roles at other biotech firms. His leadership established strong operational management foundations in the industry.
Stan Klein holds a bio/chemistry degree from City University of New York City College and a Master’s in Business from Pace University – Lubin School of Business. He is recognized for his expertise in nucleic acid purification and biotech automation technologies.
The Parallel Fluidics leadership team brings a balanced mix of technical know-how and commercial leadership, with founders and executives who have shaped the company’s innovative direction in the microfluidics and life sciences space. With deep roots in R&D, marketing, engineering, and project management, the Parallel Fluidics management team fosters a collaborative culture that prioritizes speed, invention, and client value—all vital for scaling in a fast-evolving industry.
Websets is a powerful natural language search and data enrichment tool that helps you research executive teams for any company. Whether you're analyzing the Parallel Fluidics leadership team or exploring management structures at other organizations, Websets provides comprehensive insights into executive backgrounds, roles, and team dynamics.
With Websets, you can access detailed executive team profiles, management structures, and leadership insights through intuitive natural language queries. Sign up now to enhance your executive team research capabilities.